About this trial
Over the last two decades, considerable progress has been made in the management of Acute Myocardial Infarction (AMI), both in the acute phase and in monitoring beyond the hospital phase. Nevertheless, the evolution of care practices and their impact on the mid- and long-term prognosis of patients admitted to the intensive care unit for acute myocardial infarction remain relatively little studied exhaustively.
The aim of this study is to assess the profile of AMI patients, their management and follow-up in order to evaluate the relationship between these factors and outcomes.
Eligibility criteria
Qualifiers
Symptoms compatible with myocardial ischemia
Appearance of pathological Q waves
ST- T changes compatible with myocardial ischemia (ST segment elevation or depression, T-wave inversion)
Written consent.
Disqualifiers
Iatrogenic MI defined as MI occurring within 48h of a therapeutic procedure
AMI diagnosis invalidated in favor of another diagnosis
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Assistance Publique - Hôpitaux de Paris
Lead sponsor
Novartis
Collaborator